| Trial ID: | L0759 |
| Source ID: | NCT02178839
|
| Associated Drug: |
β-glucan
|
| Title: |
The Effect of Oral β-glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver Echogenicity and Enzymes in Non Alcoholic Fatty Liver Disease Treating With Hypocaloric Diet and Vitamin E
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: ??- glucan;Dietary Supplement: Maltodextrin
|
| Outcome Measures: |
Liver Echogenicity;Liver EnzymesAnthropometric Measurement WHtR;Appetite;Insulin Resistance;Anthropometric Measurement WC;Anthropometric Measurement WHR;Anthropometric Measurement BMI;Peptide YY (PYY) Hormone;Cholecystokinin (CKK) Hormone;Fasting Blood Sugar
|
| Sponsor/Collaborators: |
Urmia University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 Years55 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
48
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
| Start Date: |
18/06/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Iran, Islamic Republic of
|
| URL: |
http://clinicaltrials.gov/show/NCT02178839
|
